In Aftermath of NEJM Article, Critic Bailar Declares The Defeat Of Cancer Treatment
In Brief: Columbia University Double Lab Space; GM Cancer Awards to Suit, Folkman, Nurse
In This Issue: The controversy Over “Cancer Undefeated”
“Imaginary Treatments,” “Wonderful Cures”
Call to Shift Two-Thirds Of Funds a “Rubber Number,” Bailar Says
Broder Says No Thanks To Acknowledgement For Paper’s Title
Letters to The Editors: Donald Coffey Finds Sensationalism Hurts
Ellen Stoval Calls For More Funding for All Cancer Research
Trending Stories
- Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma - The end of “more money, more people, more trials”
Cancer centers are being asked to grow their portfolios on flat budgets. Headcount is the wrong answer. - Harold Freeman, a surgeon who championed health equity, dies at 93
Freeman, the father of patient navigation, served as president of ACS and chair of the President’s Cancer Panel - Letai takes a swipe at “ill-informed commentators,” as he lays out his scientific vision for NCI
“To my knowledge, 100% of grants that clear my desk get funded” - Senthil K. Muthuswamy named director of NCI’s Center for Cancer Research
